Kaitlin Henry

Ms. Kaitlin Henry


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in Cells
Verified
Journal Article
Open access
PDF file
MBMarcel Brown
Marcel Brown
DBDavis James Brady
Davis James Brady
KHkelsey Healy
kelsey Healy
KHKaitlin Henry
Kaitlin Henry
AOAyobami Ogunsola
Ayobami Ogunsola
XMXue Ma
Xue Ma
Bone/fracture healing is a complex process with different steps and four basic tissue layers being affected: cortical bone, periosteum, fascial tissue surrounding the fracture, and bone marrow. Stem cells and their derivatives, including embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, skeletal stem cells, and multipotent stem cells, can function to artificially introduce highly regenerative cells into decrepit biological tissues and augment the healing process at the tissue level. Stem cells are molecularly and functionally indistinguishable from standard human tissues. The widespread appeal of stem cell therapy lies in its potential benefits as a therapeutic technology that, if harnessed, can be applied in clinical settings. This review aims to establish the molecular pathophysiology of bone healing and the current stem cell interventions that disrupt or augment the bone healing process and, finally, considers the future direction/therapeutic options related to stem cells and bone healing.

8 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MBMarcel Brown
Marcel Brown
DBDavis James Brady
Davis James Brady
KHkelsey Healy
kelsey Healy
KHKaitlin Henry
Kaitlin Henry
AOAyobami Ogunsola
Ayobami Ogunsola
XMXue Ma
Xue Ma
Bone/fracture healing is a complex process with different steps and four basic tissue layers being affected: cortical bone, periosteum, fascial tissue surrounding the fracture, and bone marrow. Stem cells and their derivatives, including embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, skeletal stem cells, and multipotent stem cells, can function to artificially introduce highly regenerative cells into decrepit biological tissues and augment the healing process at the tissue level. Stem cells are molecularly and functionally indistinguishable from standard human tissues. The widespread appeal of stem cell therapy lies in its potential benefits as a therapeutic technology that, if harnessed, can be applied in clinical settings. This review aims to establish the molecular pathophysiology of bone healing, the current stem cell interventions that disrupt or augment the bone healing process, and finally, consider the future direction/therapeutic options related to stem cells and bone healing.

12 December 2025 in Osteoarthritis and Cartilage Open
Verified
Journal Article
Open access
XMXue Ma
Xue Ma
MBMarcel Brown
Marcel Brown
MGMatthew S. Gwilt
Matthew S. Gwilt
KHKaitlin Henry
Kaitlin Henry
AOAyobami Ogunsola
Ayobami Ogunsola
TSThomas L. Smith
Thomas L. Smith
Evaluate the effect of human placental extract (HPE) on healthy and osteoarthritic articular cartilage. Post-traumatic osteoarthritis (PTOA) rodent model was utilized to assess functional and histologic outcomes of HPE administration at 1, 2 and 3 months. Matrix metalloproteinase (MMP), glycosaminoglycan (GAG) content were assessed via human and porcine cartilage explants exposed to either HPE or saline cohorts. Improved gait function of PTOA-induced rodents treated with HPE in 5 measured parameters, persisting to the 3-month time point against the saline control. No significant difference in medial or lateral joint space was found on MicroCT evaluation after normalizing results to the contralateral uninjured limb. OARSI scores of the medial compartment of PTOA rodents at 3-months showed preservation of cartilage in the HPE-treated cohort with a score of 1.8 for HPE versus 9.17 for saline (p < 0.05). Porcine cartilage explants co-treated with HPE and IL-1 demonstrated marked reduction of MMP-1 (p = 0.001) and MMP-13 (p = 0.0023) expression compared to IL-1 alone. This effect was re-demonstrated in human cartilage with multiple MMP decreased. Reduced levels of GAG release occurred in HPE-treated cartilage explants in comparison to saline control (p = 0.004), with maintenance of structural architecture on histologic preparations. HPE may be a promising treatment for OA by inhibiting the metabolic process of ECM breakdown and preserving the structural integrity of the knee joint in comparison to saline control.